Table 1.
Definitions of study variables and outcomes.
Fig 1.
Directly Observed Treatment during MDA round (DOT-MDA) across years 2010–15.
Years 2010, 2011–12, 2013, 2014, 2014 Dec, 2015.
Table 2.
Coverage rate and compliance rate over last five years.
Table 3.
Percent wise reasons for non-coverage.
Table 4.
Percent wise reasons of non-compliance among those who received drug.
Fig 2.
Baseline year 2005 and current year 2015 microfilariae rate.
Year 2005 and 2015.
Table 5.
District-wise nocturnal blood smear results and Microfilaria (MF) rate.